Evidence map›Paper›PMID 34956158›Full record

ArticleFrontiers in microbiology2021

Association of the Serum Levels of the Nucleocapsid Antigen of SARS-CoV-2 With the Diagnosis, Disease Severity, and Antibody Titers in Patients With COVID-19: A Retrospective Cross-Sectional Study.

Rin Yokoyama, Makoto Kurano, Yuki Nakano, Yoshifumi Morita, Hiroko Ohmiya, Yoshiro Kishi, Jun Okada, Chungen Qian, Fuzhen Xia, Fan He and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. tBiomolecules · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Rin YokoyamaDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Makoto KuranoDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Yuki NakanoDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Yoshifumi MoritaDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
Hiroko OhmiyaSales and Marketing Division, Business Planning Department, Medical and Biological Laboratories Co., Ltd., Tokyo, Japan.
Yoshiro KishiSales and Marketing Division, Business Planning Department, Medical and Biological Laboratories Co., Ltd., Tokyo, Japan.
Jun OkadaSales and Marketing Division, Business Planning Department, Medical and Biological Laboratories Co., Ltd., Tokyo, Japan.
Chungen QianThe Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics and Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Fuzhen XiaReagent R and D Center, Shenzhen YHLO Biotech Co., Ltd., Guangdong, China.
Fan HeReagent R and D Center, Shenzhen YHLO Biotech Co., Ltd., Guangdong, China.
Liang ZhengReagent R and D Center, Shenzhen YHLO Biotech Co., Ltd., Guangdong, China.
Yi YuReagent R and D Center, Shenzhen YHLO Biotech Co., Ltd., Guangdong, China.
Miyuki MizoguchiDepartment of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
Yoshimi HigurashiDepartment of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
Sohei HaradaDepartment of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
Daisuke JubishiDepartment of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
Koh OkamotoDepartment of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
Kyoji MoriyaDepartment of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
Tatsuhiko KodamaLaboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Yutaka YatomiDepartment of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
The University of Tokyo · JPMedical & Biological Laboratories (Japan) · JPUniversity of Tokyo Hospital · JPWuhan National Laboratory for Optoelectronics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody titercoronavirus disease 2019COVID-19diagnosisN antigennucleocapsid antigenseverity

Identifiers

PMID34956158
PMCPMC8696188
OpenAlexW4200489854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.